Dr. Chinazo Cunningham is the principal investigator in a potentially groundbreaking study into whether marijuana use could reduce the need for addictive opioids in pain management. It’s a rare opportunity given the federal restrictions on studying marijuana. Since 1970, it’s been listed as a Schedule I drug, meaning it has no medical use and there is a high potential for abuse. Despite 30 states legalizing medical marijuana, the federal government maintains there’s not enough research to suggest it has medical benefits, and this position keeps pot from being studied by researchers. Dr. Cunningham joins Soledad O’Brien to talk about her study and the Catch-22 of studying marijuana in the U.S.
Searching for “Forgotten America”
November 26, 2016Searching for “Forgotten America”
November 26, 2016
Outbreak: The First Response
June 28, 2020Outbreak: The First Response
June 28, 2020
Finding Shelter During the Pandemic: How Seattle Tackled its Homeless Crisis
June 14, 2020Finding Shelter During the Pandemic: How Seattle Tackled its Homeless Crisis
June 14, 2020
COVID-19 Rapidly Spreading in a Town of Migrant Workers Who Can’t Afford to Stay Home
June 7, 2020COVID-19 Rapidly Spreading in a Town of Migrant Workers Who Can’t Afford to Stay Home
June 7, 2020
Milwaukee Expected 50,000 Visitors for the DNC. Now They’re Looking at a Potential Loss
May 31, 2020Milwaukee Expected 50,000 Visitors for the DNC. Now They’re Looking at a Potential Loss
May 31, 2020
Who Gets Access to the Coronavirus Vaccine First?
May 31, 2020Who Gets Access to the Coronavirus Vaccine First?
May 31, 2020
Fast Tracking a Vaccine for the Virus: The Controversy over Human Challenge Trials
May 31, 2020Fast Tracking a Vaccine for the Virus: The Controversy over Human Challenge Trials
May 31, 2020
The New Ways Muslims Are Celebrating Ramadan During COVID-19
May 17, 2020The New Ways Muslims Are Celebrating Ramadan During COVID-19
May 17, 2020
